TripleMed

TripleMed develops innovative and cost-effective solutions for the treatment of aortic aneurysms, including Balloon-Based EVAR technology and polymer implants

Biotech & Life Sciences

Sector

Seed

Stage

B2B

Model

01Company Overview

TripleMed develops innovative and cost-effective solutions for the treatment of aortic aneurysms, including Balloon-Based EVAR technology and polymer implants.

02Backed By1 investor

BVBrightlands Venture Partners→

03Similar Companies